| 000 | 01274 a2200337 4500 | ||
|---|---|---|---|
| 005 | 20250514020114.0 | ||
| 264 | 0 | _c20020206 | |
| 008 | 200202s 0 0 eng d | ||
| 022 | _a1471-2598 | ||
| 024 | 7 |
_a10.1517/14712598.1.4.603 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBodey, B | |
| 245 | 0 | 0 |
_aGenetically engineered antibodies for direct antineoplastic treatment and systematic delivery of various therapeutic agents to cancer cells. _h[electronic resource] |
| 260 |
_bExpert opinion on biological therapy _cJul 2001 |
||
| 300 |
_a603-17 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xchemistry |
| 650 | 0 | 4 |
_aAntigens, Neoplasm _ximmunology |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadministration & dosage |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 | _aDrug Carriers |
| 650 | 0 | 4 | _aDrug Delivery Systems |
| 650 | 0 | 4 | _aGenetic Engineering |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunotherapy _xmethods |
| 650 | 0 | 4 |
_aImmunotoxins _xchemistry |
| 650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
| 773 | 0 |
_tExpert opinion on biological therapy _gvol. 1 _gno. 4 _gp. 603-17 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1517/14712598.1.4.603 _zAvailable from publisher's website |
| 999 |
_c11641540 _d11641540 |
||